NCT06257082 Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
| NCT ID | NCT06257082 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Diabetic Retinopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,526 participants |
| Start Date | 2025-05-21 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,526 participants in total. It began in 2025-05-21 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An online survey (n=1,500) and 4 focus groups will be conducted with Latinx patients with diabetes (n=20) to obtain preliminary data regarding whether and how patient and clinician video testimonial interventions (n=6) increase eye health literacy and trust in healthcare.
Eligibility Criteria
Inclusion Criteria (online survey participants): * Self-Identifies as Hispanic or Latino Inclusion Criteria (patient video testimonials): * Self-Identifies as Hispanic or Latino * diagnosed with diabetes * treated at Access Community Health Centers and UW Health in Madison, WI Inclusion Criteria (clinician video testimonials): * Self-Identifies as Hispanic or Latino * clinician who treats patients with diabetes at Access Community Health Centers and UW Health in Madison, WI Inclusion Criteria (focus group participants): * Self-Identifies as Hispanic or Latino * diagnosed with type 1 or type 2 diabetes Exclusion Criteria: \-
Contact & Investigator
Yao Liu, MD, MS
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT06257082 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetic Retinopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06257082 currently recruiting?
Yes, NCT06257082 is actively recruiting participants. Contact the research team at cmaldonado5@wisc.edu for enrollment information.
Where is the NCT06257082 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT06257082 clinical trial?
NCT06257082 is sponsored by University of Wisconsin, Madison. The principal investigator is Yao Liu, MD, MS at University of Wisconsin, Madison. The trial plans to enroll 1,526 participants.